fluorodopa f 18 has been researched along with Insulinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, E; El-Rabadi, K; Hacker, M; Haug, A; Karanikas, G; Nakuz, TS; Wadsak, W | 1 |
| Cuccurullo, V; Di Stasio, GD; Mansi, L | 1 |
| Basher, RK; Behera, A; Bhattacharya, A; Kang, M; Mittal, BR; Nada, R; Shukla, J; Sood, A; Walia, R | 1 |
| Bachellier, P; Castinetti, F; Guillet, B; Imperiale, A; Kessler, L; Moreau, F; Mundler, O; Namer, IJ; Sebag, F; Taïeb, D; Vix, M | 1 |
| Bachellier, P; Bahougne, T; Goichot, B; Imperiale, A; Namer, IJ; Taïeb, D | 1 |
| Boisson, F; Brasse, D; Detour, J; Imperiale, A; Kessler, L; Kreutter, G; Lavaux, T; Marchand, P; Namer, IJ; Pierre, A | 1 |
| Conte-Devolx, B; De Micco, C; Ghander, C; Henry, JF; Mundler, O; Palazzo, FF; Reynaud, R; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
1 review(s) available for fluorodopa f 18 and Insulinoma
| Article | Year |
|---|---|
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Humans; Indium Radioisotopes; Insulinoma; Ligands; Mice; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin | 2019 |
6 other study(ies) available for fluorodopa f 18 and Insulinoma
| Article | Year |
|---|---|
Clinical Value of
Topics: Adult; Aged; Aged, 80 and over; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Insulinoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Premedication; Radiopharmaceuticals; Retrospective Studies | 2018 |
68Ga-DOTA-Exendin PET-MRI Fusion Imaging in a Case of Insulinoma.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Insulinoma; Magnetic Resonance Imaging; Multimodal Imaging; Organometallic Compounds; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
18F-FDOPA PET/CT imaging of insulinoma revisited.
Topics: Adult; Aged; Aged, 80 and over; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Insulinoma; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Hypoglycemia; Insulinoma; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Topics: Animals; Carbidopa; Cell Line, Tumor; Dihydroxyphenylalanine; Female; Image Enhancement; Insulinoma; Metabolic Clearance Rate; Mice, Nude; Organ Specificity; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2017 |
Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
Topics: Adolescent; Adult; Aged; Child; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Hypoglycemia; Insulin-Secreting Cells; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Young Adult | 2010 |